Prospective study of efficacy and safety of Radiotherapy in combination with KORTUC for Breast Cancer.
Phase 2
Recruiting
- Conditions
- breast cancer
- Registration Number
- JPRN-UMIN000018131
- Lead Sponsor
- Kobe Minimally Invasive Cancer Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
1)prior history of radiation therapy in the thoracic. 2)Severe complication 3)History of hypersensitivity to hyaluronic acid 4)History of hypersensitivity to lidocaine hydrochloride 5)History of hypersensitivity to H2O2 6)investigator judged ineligible
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Response rate local control rate
- Secondary Outcome Measures
Name Time Method Progression free survival (PFS), Overall survival (OS), safty profile